IP Library Assignment 018171/0872
Patent Assignment
Reel/Frame 018171/0872

Assignment of Assignor's Interest

Recorded: 2006-08-28 Pages: 3
Assignor
WATSON PHARMACEUTICALS, INC.
Executed: 2006-08-21
Assignee
WATSON LABORATORIES, INC.
577 CHIPETA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property (1)
Compositions and Methods for Minimizing Adverse Drug Experiences Associated with Oxybutynin Therapy
Patent: 6,743,441 →
Application: 10/098,752 →
Publication: US 2002/0147236
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 14, 2006
From: SANDERS, STEVEN W.; EBERT, CHARLES D.
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 017776/0417 →
Assignment of Assignor's Interest Sep 26, 2016
From: ACTAVIS LABORATORIES UT, INC.
To: ALLERGAN SALES, LLC
Reel/Frame 039857/0661 →